Your browser doesn't support javascript.
loading
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets.
Zheng, Fang; Liao, Yi-Ji; Cai, Mu-Yan; Liu, Tian-Hao; Chen, Shu-Peng; Wu, Pei-Hong; Wu, Long; Bian, Xiu-Wu; Guan, Xin-Yuan; Zeng, Yi-Xin; Yuan, Yun-Fei; Kung, Hsiang-Fu; Xie, Dan.
Afiliação
  • Zheng F; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Medical Research Center, Sun Yat-Sen Memorial Hospital, Guangzhou, China.
  • Liao YJ; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Cai MY; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Liu TH; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Medical Research Center, Sun Yat-Sen Memorial Hospital, Guangzhou, China.
  • Chen SP; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wu PH; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Tumor Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, China; Hepatobiliary Oncology, Sun Yat-Sen University Cance
  • Wu L; Department of Clinical Oncology, People's Hospital, Wuhan University, Wuhan, China.
  • Bian XW; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Guan XY; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Clinical Oncology, the University of Hong Kong, Hong Kong, China.
  • Zeng YX; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Yuan YF; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Kung HF; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; State Key Laboratory of Oncology in South China, the Chinese University of Hong Kong, Hong Kong, China.
  • Xie D; The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
PLoS Genet ; 11(2): e1004873, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25693145

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Terapia de Alvo Molecular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Terapia de Alvo Molecular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China